click below
click below
Normal Size Small Size show me how
T2DM
DM Drug MOA
| Question | Answer |
|---|---|
| Alpha-Glucosidase Inhibitors | Delay digestion of carbohydrates |
| Amalyin Analog | Prolongs gastric emptying, Reduces postprandial glucagon secretion, Suppresses appetite |
| Biguanide | Decreases hepatic glucose production, Decreases intestinal absorption of glucose, Improves insulin sensitivity |
| DPP-IV Inhibitors | inhibits DPP-IV which breaks down GLP-1, therefore increasing insulin secretion and suppressing glucagon secretion |
| GLP-1 Agonists | increases insulin secretion and suppresses glucagon secretion through mimicking the effects of GLP-1 |
| Meglitinides | stimulate the release of insulin from the pancreas |
| SGLT-2 Inhibitors | increases renal excretion of glucose by preventing reabsorption in the kidneys, also increases the amount of glucose filtered by the kidneys |
| Sulfonylureas | increases the secretion of insulin by the pancreas |
| TZDs | increase target cell insulin sensitivity through ppar gamma agonism |